National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

carcinoembryonic antigen peptide 1-6D
A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). CEA:571-579 peptide, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CEA:571-579 (576D)
mCEA Peptide
Modified CEA Peptide
Abbreviations:CAP-1-6D peptide
CEA PEP 1-6D



Previous:carbon-11 acetate, carboplatin, carboxyamidotriazole, carboxyphenyl retinamide, carcinoembryonic antigen peptide 1
Next:carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine, Cardizem, Carmubris, carmustine, Carnitor

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov